April 12 (Reuters) - Endo International PLC ENDP.O
* ADVANZ PHARMA AND ENDO ANNOUNCE PARTNERSHIP FOR PALADIN LABS TO COMMERCIALIZE XYDALBA (DALBAVANCIN HYDROCHLORIDE) IN CANADA
* ENDO INTERNATIONAL PLC - ADVANZ PHARMA WILL BE RESPONSIBLE FOR SUPPLYING THE DRUG
* ENDO INTERNATIONAL - ENDO VENTURES WILL BE RESPONSIBLE FOR DISTRIBUTION, SALES, MARKETING, MEDICAL AFFAIRS, PRICING & REIMBURSEMENT ACTIVITIES IN CANADA